EU Strengthens Heart Warnings on Merck & Co., Inc.'s (JOBS) Arcoxia

June 27, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, June 26 (Reuters) - The European Medicines Agency said on Thursday it had concluded that Merck & Co's Arcoxia can be used to treat rheumatoid arthritis and ankylosing spondylitis but with heightened warnings on cardiovascular risks.

Twitter
LinkedIn
Facebook
Email
Print

Europe

Merck & Co.